For a more in-depth look, explore the live dashboard tracking Prenetics global’s ongoing accumulation of Bitcoin—detailing unit count, cost average, profit & loss, and how the company’s Bitcoin holdings relate to its stock and overall valuation at the original source:
https://droomdroom.com/bitcoin-treasury-tracker/prenetics

Prenetics Global Limited is a Hong Kong–headquartered health sciences company focused on advancing preventive healthcare through genomics, wellness, and digital innovation. Founded in 2014, the company operates a diversified portfolio that includes CircleDNA, a direct-to-consumer genetic testing platform offering deep insights into health, nutrition, and ancestry, as well as IM8, a wellness brand aimed at optimizing everyday health. Through its Europa division, Prenetics also participates in sports and lifestyle distribution, expanding its consumer reach beyond diagnostics.

A distinctive aspect of Prenetics is its early adoption of a Bitcoin treasury strategy within the healthcare sector. By designating Bitcoin as a core reserve asset, the company aims to diversify its balance sheet while aligning with emerging financial technologies. Prenetics further explores blockchain integration to enhance data security, privacy, and integrity across its genomics platforms. Led by CEO Danny Yeung and supported by high-profile partnerships, Prenetics sits at the intersection of health tech and digital assets, positioning itself as a forward-looking player in the global preventive healthcare ecosystem.

For a more in-depth look, explore the live dashboard tracking Prenetics global’s ongoing accumulation of Bitcoin—detailing unit count, cost average, profit & loss, and how the company’s Bitcoin holdings relate to its stock and overall valuation at the original source:
https://droomdroom.com/bitcoin-treasury-tracker/prenetics

Prenetics Global Limited is a Hong Kong–headquartered health sciences company focused on advancing preventive healthcare through genomics, wellness, and digital innovation. Founded in 2014, the company operates a diversified portfolio that includes CircleDNA, a direct-to-consumer genetic testing platform offering deep insights into health, nutrition, and ancestry, as well as IM8, a wellness brand aimed at optimizing everyday health. Through its Europa division, Prenetics also participates in sports and lifestyle distribution, expanding its consumer reach beyond diagnostics.

A distinctive aspect of Prenetics is its early adoption of a Bitcoin treasury strategy within the healthcare sector. By designating Bitcoin as a core reserve asset, the company aims to diversify its balance sheet while aligning with emerging financial technologies. Prenetics further explores blockchain integration to enhance data security, privacy, and integrity across its genomics platforms. Led by CEO Danny Yeung and supported by high-profile partnerships, Prenetics sits at the intersection of health tech and digital assets, positioning itself as a forward-looking player in the global preventive healthcare ecosystem.